Who is sponsoring NCT05374694?

NCT05374694 is sponsored by Hospital Arnau de Vilanova.

What drugs are being tested in NCT05374694?

Interventions in NCT05374694: Physiological invasive coronary evaluation.

What condition does NCT05374694 study?

NCT05374694 studies Angina Pectoris.

Is NCT05374694 still recruiting?

NCT05374694 is currently status unknown. Last updated 19 October 2022.

Last reviewed 2022-10-19 · How we verify

NCT05374694: ANFIBIO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Angina, Physiology, Biology (ANgina, FIsiologia BIOlogia)

Status unknown Last updated 19 October 2022

What this trial tests

trial testing Physiological invasive coronary evaluation in Angina Pectoris in 100 participants. Status unknown.

Timeline

8 May 2022

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Hospital Arnau de Vilanova
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	8 May 2022
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Spain

Drugs / interventions tested

Physiological invasive coronary evaluation

Conditions studied

Angina Pectoris — all drugs for Angina Pectoris →

Sponsor

Hospital Arnau de Vilanova

Who can join

18 and older, any sex, with Angina Pectoris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Relationship between invasive physiological assessment with FFR and IMR and biological markers as micro-RNA's according to coronary vascular compartiment affected (Group 1: Macrovasculature + / Microvasculature +; Group 2: Macrovasculature + / Microvasculature -; Group 3: Macrovasculature - / Microvasculature +; Group 4: Macrovasculature - / Microvasculature -). Also, biological markers will be related with presence of microvascular spasm or macrovascular spasm (Group 5).

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications.
Li Z, Zhao Y, Suguro S, Suguro R. · · 2023 · cited 12× · PMID 37675243 · DOI 10.1155/2023/2561509
Study protocol for the epigenetic characterization of angor pectoris according to the affected coronary compartment: Global and comprehensive assessment of the relationship between invasive coronary physiology and microRNAs.
Matute-Blanco L, Fernández-Rodríguez D, Casanova-Sandoval J, Belmonte T, et al · · 2023 · cited 1× · PMID 37167303 · DOI 10.1371/journal.pone.0283097
Plasma miR-502-5p and coronary artery vasospasm: An exploratory study.
Matute-Blanco L, Sánchez-Rodríguez M, Casanova-Sandoval J, Garcia-Guimaraes M, et al · · 2026 · PMID 42209331 · DOI 10.1016/j.arteri.2026.500947
Physiological Characterization of Coronary Endotypes: Potential Links with Myocardial Ischemia.
Matute-Blanco L, Belmonte T, Rivera K, García-Guimaraes M, et al · · 2025 · PMID 41637324 · DOI 10.36660/abc.20250340

Verify or expand the search:

Other recruiting trials for Angina Pectoris

Currently open trials in the same condition.

NCT06384846 — AI Algorithms in Prediction of ACS Based on Leukocyte Properties · recruiting
NCT05492110 — Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microva · NA · recruiting
NCT05493904 — PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX) · NA · active not recruiting
NCT06075602 — COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLE · recruiting
NCT04988685 — SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With · recruiting

Other Hospital Arnau de Vilanova trials

Trials by the same sponsor.

NCT07519304 — Effectiveness of a Needle-free Connector With Anti-reflux Technology in Reducing Complications From Long Peripheral Veno · NA · not yet recruiting
NCT06770374 — Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Ca · NA · recruiting
NCT06476054 — Optimal Timing for Laparoscopic Cholecystectomy After Cholecystostomy in Acute Cholecystitis Tokyo II/III Setting · NA · recruiting
NCT06148376 — Application of a Protocol of Personalized Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Doses of Insul · completed
NCT06770361 — Creation of a Vascular Access Specialist Teams Within an Interventional Vascular Radiology Service: a Retrospective Obse · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05374694 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Arnau de Vilanova
Last refreshed: 19 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05374694.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing